Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01035606 · ClinicalTrials.gov registry record · NA

Training in Goal-directed Attention Regulation for Individuals With Brain Injury

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
49
Enrollment target

NCT01035606: Completed NA study, sponsored by VA Office of Research and Development.

NCT01035606 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 49 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01035606, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
49 participants
Enrollment target

Study Summary

Brain injuries affect the lives of numerous Veterans. This study examines how the brain is affected by injury and how rehabilitation training for attention dysfunction may change brain functioning.

Primary Outcome

Responses to goal processing questionnaire relating to areas of personal goal-based functioning. This scale measured participants self-perceived changes to their cognitive and emotional functioning. Participants indicated the degree to which they perceived changes to 11 questions after receiving trainings in Arm 1 and Arm 3 on a 10-point scale (1=domain became worse, 5 = no change, 10 = domain improved). Participants did not complete this measure after Arm 2.

Interventions

  • BEHAVIORAL training in goal-directed attention regulation
  • BEHAVIORAL brain health education
  • BEHAVIORAL computer-assisted training in goal-directed attention regulation

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2009-09
Est. Completion 2017-04
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT01035606 record still lists

NCT01035606 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 3 interventions - of which training in goal-directed attention regulation is the first listed.

NCT01035606 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01035606 about?

NCT01035606 is a clinical study titled "Training in Goal-directed Attention Regulation for Individuals With Brain Injury". Brain injuries affect the lives of numerous Veterans. This study examines how the brain is affected by injury and how rehabilitation training for attention dysfunction may change brain functioning.

What is the current status of trial NCT01035606?

This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2009-09. Estimated completion is 2017-04.

What interventions are being tested in trial NCT01035606?

The interventions under investigation include: training in goal-directed attention regulation (BEHAVIORAL), brain health education (BEHAVIORAL), computer-assisted training in goal-directed attention regulation (BEHAVIORAL).

Who is sponsoring clinical trial NCT01035606?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01035606's enrollment target sits among peer trials

49 1379th of 2000 higher than 620 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02704858 · 49 participants · Phase 1

    Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

  • NCT03516708 · 49 participants · Phase 1

    Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer

  • NCT03692429 · 49 participants · Phase 1

    alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells

  • NCT04329494 · 49 participants · Phase 1

    PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01035606, the US trial registry maintained by the National Library of Medicine. NCT01035606 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.